Bacterial membrane lipids and biofilm extracellular polymeric substances

Bacterial membrane lipids and the biofilm extracellular polymeric substance (EPS) matrix are fundamental structural components that ensure the survival and pathogenicity of bacteria (Nature Reviews Microbiology, 2010). The cytoplasmic membrane, primarily composed of phospholipids like phosphatidylglycerol, serves as a selective permeability barrier and a scaffold for essential proteins (PubMed, 2014). In many species, bacteria further protect themselves by secreting an EPS matrix consisting of polysaccharides, proteins, and extracellular DNA (eDNA), which facilitates the formation of biofilms (Nature Reviews Microbiology, 2010). These biofilms are notoriously difficult to treat because the matrix acts as a physical and chemical shield against both the host immune system and conventional antibiotics (PubMed, 2012). Therapeutic strategies targeting these structures include membrane-disrupting agents like daptomycin and polymyxins, which induce rapid cell death by compromising membrane potential or integrity (StatPearls, 2023). Additionally, matrix-degrading enzymes like dornase alfa are used to disperse biofilms and sensitize bacteria to standard treatments (PubMed, 2010). Despite their efficacy, these targets present challenges such as potential toxicity to host tissues and the rapid evolution of bacterial resistance mechanisms (NIH, 2021).

Other names

Bacterial cell membraneBiofilm matrixExtracellular polymeric substancesEPSBacterial lipid bilayer

Drugs targeting these structures act by physically disrupting the bacterial lipid bilayer to cause leakage of cellular contents and loss of membrane potential, or by enzymatically degrading the biofilm matrix to facilitate antibiotic penetration and host immune clearance.